Practical Guidance for the Community Oncologist — Incorporating Advances in Therapy for Metastatic TNBC: A Focus on TROP2
Click the "View Activity" button to view this activity.View Activity
Activity already occured. CME/CE is no longer available for this activity
• Discuss new and emerging targeted treatment approaches in the setting of TNBC
• Discuss the role of ADC therapies and TROP2 for TNBC
• Implement strategies to facilitate the use of novel and emerging therapies for TNBC in community-based settings
• TNBC treatment challenges
• ADC mechanistic rationale
• Role of TROP2 in TNBC
• Case-based application of current data and recommendations
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Professor of Medicine
University of California, Los Angeles (UCLA)
Co-Director, Santa Monica-UCLA Outpatient Oncology Practice
Medical Director, Clinical Research Unit
Jonsson Comprehensive Cancer Center at UCLA
Director of Breast Oncology
Simms/Mann UCLA Center for Integrative Oncology
Los Angeles, CA
In support of improving patient care, Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.